Ira Weinryb

Immunology and Microbiology · Life Sciences

19h-index2.3kcitations75works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Mast cells and histamine(13), Receptor Mechanisms and Signaling(9), Asthma and respiratory diseases(6), Phosphodiesterase function and regulation(6), Phenothiazines and Benzothiazines Synthesis and Activities(6)

Publications72 total

Fit-for-Purpose Method Development and Validation for Successful Biomarker Measurement
Pharmaceutical Research·2006· 744 cited
Bioavailability of amiodarone tablets administered with and without food in healthy subjects
The American Journal of Cardiology·2001· 70 cited
A Pharmacokinetic and Pharmacodynamic Study of the Potential Drug Interaction between Tasosartan and Atenolol in Patients with Stage 1 and 2 Essential Hypertension
The Journal of Clinical Pharmacology·2000· 2 cited
Population distribution and effects on drug metabolism of a genetic variant in the 5′ promotor region of CYP3A4
Clinical Pharmacology & Therapeutics·1999· 233 cited
Disclosure of analytical information in pharmacokinetic papers
Clinical Pharmacology & Therapeutics·1997
Chylous Transport of Amiodarone
CHEST Journal·1993Open Access
ChemInform Abstract: Substituted Arylmethyl Phenyl Ethers (I). Part 1. A Novel Series of 5‐Lipoxygenase Inhibitors and Leukotriene Antagonists.
ChemInform·1987
REV 2871 (CHBZ): A potent antiallergic agent with a novel mechanism of action
Biochemical Pharmacology·1987· 10 cited
REV 2871 (CHBZ): A potent antiallergic agent with a novel mechanism of action
Biochemical Pharmacology·1987· 4 cited
Substituted arylmethyl phenyl ethers. 1. A novel series of 5-lipoxygenase inhibitors and leukotriene antagonists
Journal of Medicinal Chemistry·1987· 50 citedOpen Access
ChemInform Abstract: Angiotensin‐Converting Enzyme Inhibitors: New Orally Active 1,4‐Thiazepine‐ 2,5‐diones, 1,4‐Thiazine‐2,5‐diones, and 1,4‐Benzothiazepine‐2,5‐ diones Possessing Antihypertensive Activity.
Chemischer Informationsdienst·1986· 3 cited
REV 2871 (CHBZ): A novel inhibitor of histamine release
Inflammation Research·1986· 5 cited
ChemInform Abstract: Angiotensin‐converting Enzyme Inhibitors: N‐Substituted Glycine Derivatives.
Chemischer Informationsdienst·1986
ChemInform Abstract: ANGIOTENSIN‐CONVERTING ENZYME INHIBITORS. NEW ORALLY ACTIVE ANTIHYPERTENSIVE (MERCAPTOALKANOYL)‐ AND ((ACYLTHIO)ALKANOYL)GLYCINE DERIVATIVES
Chemischer Informationsdienst·1985· 2 cited
Arylmethyl Phenyl Ethers A New Class of Specific Inhibitors of 5-Lipoxygenase
1985· 22 cited
Arylmethyl Phenyl Ethers
1985· 16 cited
Correlation of and activities of a series of arylmethyl phenyl ethers with 5-lipoxygenase (LOX) inhibitory properties
International Journal of Immunopharmacology·1985
Effects of celiprolol (REV 5320), a new cardioselective beta-adrenoceptor antagonist, on in vitro adenylate cyclase, alpha- and beta-adrenergic receptor binding and lipolysis.
PubMed·1984· 23 cited
Comparative structure-activity relationships for dihydropyridines as inhibitors of [3H]-nitrendipine binding vs cyclic nucleotide phosphodiesterases.
PubMed·1984
Current Trends in Clinical Pharmacokinetics
Clinical Research Practices and Drug Regulatory Affairs·1984
page 1 of 4Next →

Frequent Co-authors

Atul Khandwala(19), Stephen M. Coutts(14), Inge M. Michel(10), E. S. Neiss(7), Robert F. Steiner(6), JOHN H. MUSSER(6), Sidney M. Hess(4), Richard Van Inwegen(4), Vernetta Dally-Meade(4), Bernard Loev(4), Utpal Chakraborty(3), Thaddeus P. Pruss(3), Howard Jones(3), John T. Suh(3), N. Jariwala(3), H. Jones(3), Philip R. Mayer(2), John Bruens(2), Navin Jariwala(2), Richard Ingram(2)